Feasibility of establishing PVC in the Ugandan health system

By Juliet & MartinSeptember 2004

Why monitor drugs

To document unknown Adverse Drug Reactions (ADR) and maximize safety

To encourage health professionals to share concerns about drugs – create an awareness of safety issues & drugs

What should be monitored?

All drugs, but priority to be given to ARVs, anti malarials, TB drugs.

Which reports to be investigated?

All suspected ADR but with special emphasis on unexpected ADRs and those that significantly affect compliance

Who monitors?

Health workers and care givers

The PV teams and MTC

How should monitoring occur?

patients

NPVC

HW

RPVC

monitoring

Monitoring

monitoring

monitoringRegular reports

Less regular

When to encourage reporting events or reactions

2 weeks to one month

How to manage non serious events

Sensitization of patients and health workers on frequent occurrences that may affect compliance

Resources available

HR can be mobilized

Financial resources are limited and needs mobilizing

Critical success factors

Adequate financial resources

Good communication

A good infrastructure (labs, equipment etc)

Well trained and sensitized health workers

Good will by all parties